Ledger.Open graph →

SEC Form D · filed February 14, 2025

Cyclacel Pharmaceuticals, Inc

Offering

—

Sold

—

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BERKELEY HEIGHTS, NJ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

David Lazar · Berkeley Heights, NJExec Avraham F. Ben-Tzvi · Berkeley Heights, NJDirector Spiro Rombotis · Berkeley Heights, NJDirector Samuel L. Barker · Berkeley Heights, NJDirector Paul Mcbarron · Berkeley Heights, NJDirector David F. Natan · Berkeley Heights, NJDirector Avraham F. Ben-Tzvi · Berkeley Heights, NJDirector David Lazar · Berkeley Heights, NJExec David F. Natan · Berkeley Heights, NJDirector Andrea C. Jackson · Durham, NCDirector James C. Collins, Jr · Durham, NCDirector Passco Turfway Manager, LLC · Irvine, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗